Laurie Goodman

Sep 27, 2018

ClearLight Diagnostics has appointed Laurie Goodman as CEO. Goodman had been serving as interim CEO since 2018 and chief scientific officer since 2015. She will continue serving as board manager and provide executive leadership for the firm moving forward. Prior to ClearLight, Goodman was senior director of scientific and medical affairs for Biodesix, and held senior level positions at Affymetrix, Monogram Biosciences, and Lynx Therapeutics.